Association between the TaqI polymorphism of Vitamin D Receptor gene and lepromatous leprosy in a Mexican population sample;Relación del polimorfismo TaqI del gen del receptor de la vitamina D con la lepra lepromatosa en población mexicana

Salud Publica de Mexico

Volumn 51, Issue 1, 2009, Pages 59-61

  Velarde Félix, Jesús Salvador ^a,b   Cázarez Salazar, Silvestre Guadalupe ^a   Castro Velázquez, Rafael ^a,b   Rendón Maldonado, José Guadalupe ^b   Rangel Villalobos, Héctor ^c  

^a Servicios de Salud de Sinaloa   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Lepromatous leprosy; Mexican population; Mexico; Polymorphism

Indexed keywords

CALCITRIOL RECEPTOR; TAQ POLYMERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LEPROMATOUS LEPROSY; MALE; MEXICO; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEPROSY, LEPROMATOUS; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; TAQ POLYMERASE; YOUNG ADULT;

EID: 61549119775     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342009000100011     Document Type: Article

References (16)

1. López-Antuñano F. Diagnóstico y tratamiento de la lepra. Salud Publica Mex 1998;40:1-10.
2. Eden W, Gonzalez NM, de Vries RR, Convit J, van Rood JJ. HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis 1985; 151:9-14.
3. Anuario de Morbilidad 2007. Sistema Único de Información Epidemiológica. México: Secretaría de Salud, Dirección General de Epidemiología, 2007.
4. Gorodezky C, Flores J, Arevalo N, Castro LE, Silva A, Rodriguez O. Tuberculoid leprosy in mexicans is associated with HLA-DR3. Lepr Rev 1987; 58: 401-406.
5. Taylor JA, Hirvonen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996;56:4108-4110.
6. Seyhan S, Javascaoglu I, Kilickrslan H, Dogan HS, Kordan Y. Association of vitamin D receptor gene TaqI polymorphism with recurrent urolithiasis in children. Int J Urol 2007;14:1060-1062.
7. Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006;40:469-486.
8. Roy S, Frodsham A, Saha B, Hazra SK, Mascie-Taylor CG, Hill AV. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999;179:187-191.
9. Fitness J, Floyd S, Warndorff DK, Sichali L, Mwaungulu L, Crampin AC, et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004;71:330-340.
10. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966;34:255-273.
11. Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991;11:298-302.
12. Bornman L, Campbell SJ, Fielding K, Bah B, Sillah J, Gustafson P, et al. Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 2004;190: 1631-1641.
13. Rigby WF. The immunobiology of vitamin D. Immunol Today 1988;9:54-58.
14. Gelder CM, Hart KW, Williams OM, Lyons E, Welsh KI, Campbell IA, et al. Vitamin D receptor gene polymorphisms and susceptibility to Mycobacterium malmoense pulmonary disease. J Infect Dis 2000;181:2099-2102.
15. Selvaraj P, Chandra G, Jawahar MS, Rani MV, Rajeshwari DN, Narayanan PR. Regulatory role of vitamin D receptor gene variants of BsmI, ApaI, TaqI, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol 2004;24:523-532.
16. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-163.